Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04329767 · ClinicalTrials.gov registry record
A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a Three-dimensional (3-D) Anatomical Modeling Software for Pre-operative Surgical Planning and Intra-operative Navigation for Nephrectomy
A clinical trial of Kidney Cancer, sponsored by Intuitive Surgical.
- Completed
- Registry status
- 122
- Enrollment target
- 2
- Study locations
NCT04329767: Completed study of Kidney Cancer, sponsored by Intuitive Surgical.
NCT04329767 is a study of Kidney Cancer that has completed, run by Intuitive Surgical. The registered enrollment target is 122 participants, below the 878-participant average among 60 other Kidney Cancer trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04329767, a study of Kidney Cancer, has completed, sponsored by Intuitive Surgical.
- COMPLETED
- Registry status
- 122 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, multi-center, post-market study to evaluate the clinical utility of IRIS, a 3D anatomical modeling software, with standard CT scans during pre-operative planning and intra-operative navigation for nephrectomy. The study will be conducted over the course of 21-24 months and enroll approximately 60-120 subjects.
Primary Outcome
1. Interpretation of the anatomy 2. Procedure efficiency, 3. Sufficient information to use intraoperatively, and 4. Impact on the clinical practice
Conditions Studied
Interventions
- DEVICE IRIS 1.0
Study Locations (2)
New Jersey
- Hackensack University Medical Center - Edison
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2020-09-18 |
| Est. Completion | 2023-08-31 |
What the finished NCT04329767 record still lists
NCT04329767 is an observational study that tracks outcomes without assigning an intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 878-participant average among 60 other Kidney Cancer trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Kidney Cancer appearing as the primary indexed condition, and to 1 intervention - of which IRIS 1.0 is the first listed.
NCT04329767 reports a single indexed study location in New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT04329767 about?
NCT04329767 is a clinical study titled "A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a Three-dimensional (3-D) Anatomical Modeling Software for Pre-operative Surgical Planning and Intra-operative Navigation for Nephrectomy". This is a prospective, multi-center, post-market study to evaluate the clinical utility of IRIS, a 3D anatomical modeling software, with standard CT scans during pre-operative planning and intra-operative navigation for nephrectomy. The study will be conducted over the course of 21-24 months and enr...
What is the current status of trial NCT04329767?
This trial is currently completed. The enrollment target is 122 participants. The study started on 2020-09-18. Estimated completion is 2023-08-31.
What conditions does trial NCT04329767 study?
This clinical trial studies the following conditions: Kidney Cancer.
What interventions are being tested in trial NCT04329767?
The interventions under investigation include: IRIS 1.0 (DEVICE).
Who is sponsoring clinical trial NCT04329767?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04329767 being conducted?
This trial has 2 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04329767's enrollment target sits among peer trials
122 22nd of 60 higher than 39 of 60 other Kidney Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
RECRUITING · NA
-
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
RECRUITING
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RECRUITING
-
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
RECRUITING
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
-
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03363373 · 122 participants · Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- NCT03463954 · 122 participants · NA
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- NCT04503265 · 122 participants · Phase 1
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- NCT04700527 · 122 participants · Phase 1
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI